Home » Health » Parkinson’s Disease Research: New Tracer for Early Diagnosis & Treatment

Parkinson’s Disease Research: New Tracer for Early Diagnosis & Treatment

by Dr. Michael Lee – Health Editor

Generous Funding ⁤Fuels ParkinsonS Research at Karolinska Institutet

A⁢ new study investigating the progression of Parkinson’s disease has received⁢ vital support from the Michael J. Fox Foundation for Parkinson’s Research, bolstering efforts at Karolinska institutet (KI). Led by Professor Andrea Varrone of the Department of‌ Clinical⁤ Neuroscience, the research ‌focuses on utilizing advanced ⁢PET (positron emission tomography) ⁢technology to visualize synaptic connections in the brain.

Professor ⁣Varrone’s team has developed a radioligand,[[[[11C]UCB-1A, designed‌ to bind to synapses – the crucial links between nerve⁤ cells. As synapse loss is a⁤ hallmark of Parkinson’s disease, this tracer​ holds meaningful promise for deepening ⁢understanding of⁣ the disease’s mechanisms and evaluating the effectiveness of ⁣potential therapies.The study will⁢ involve both healthy⁤ individuals and those diagnosed with Parkinson’s, aiming to determine the⁢ tracer’s reliability for diagnostic purposes.

“It is an​ significant⁤ step forward both​ for‍ my research and for the field in general,” says Professor‌ Varrone. “The results can enable earlier diagnosis and better evaluation of new ⁢treatments, and in the long run ​it can contribute to more⁣ efficient and individualized care.”

The ​research benefits significantly from‍ KI’s robust infrastructure, including access to advanced imaging core facilities within the Bioclinicum. ⁣Moreover,‌ the ​proximity​ of the New Karolinska Hospital fosters crucial collaboration ‌between preclinical and clinical research,⁢ accelerating the translation of discoveries into tangible patient⁢ benefits.

Professor Varrone emphasizes⁤ the importance of⁤ this connection, stating, “The ‌strategic location…makes it possible to collaborate closely…something that is⁣ crucial for quickly ⁤translating new discoveries⁢ into patient benefits.”​ He hopes the study will demonstrate the safety and efficacy‌ of[[[[11C]UCB-1A, paving the way for its future use as a diagnostic tool and a method for monitoring treatment⁤ response in Parkinson’s disease.

Bild:

Rubric:

Andrea Varro. photo: N/A

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.